SFTPC and lung disorder: In utero delivery of Ad carrying CRISPR reagents into the amniotic cavity of a fetus (at E16) resulted in transduction of alveolar epithelial cells of fetal lung, extensive pulmonary gene editing, and, finally, rescued a perinatal lethal phenotype in the surfactant protein C (Sftpc)I73T mice, a model for monogenic lung disease